🔎 Trials Near Me

Akèy › Degeneresans makile › Arizona › Phoenix

Etid klinik pou Degeneresans makile nan Phoenix, AZ

7 etid pou Degeneresans makile ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Ap rekriteFaz 1/2
  • Associated Retina Consultants, Phoenix
Laj 55 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07029945

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Ap rekriteFaz 3
  • Barnet Dulaney Perkins Eye Center, Phoenix
  • Associated Retina Consultants, Phoenix
  • Retinal Research Institute, Phoenix
Laj 50 a 85 · Tout sèks · Mizajou Sep 18, 2026 · NCT06541704

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

Ap rekriteFaz 1
  • Associated Retina Consultants, Phoenix
Laj 6 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07734064

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Ap rekriteFaz 2
  • Associated Retina Consultants, Phoenix
Laj 55 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06659445

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Ap rekriteEtid obsèvasyon
  • Associated Retina Consultants, Phoenix
Laj 6 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Ap rekriteFaz 1/2
  • Barnet Delaney Perkins Eye Center, Phoenix
Laj 50 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT05197270

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Ap rekriteFaz 2
  • Adverum site 126, Phoenix
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07630649

Etid Degeneresans makile nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.